Michael F. Johnson

642 total citations
14 papers, 511 citations indexed

About

Michael F. Johnson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Nutrition and Dietetics. According to data from OpenAlex, Michael F. Johnson has authored 14 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 4 papers in Nutrition and Dietetics. Recurrent topics in Michael F. Johnson's work include Neuropeptides and Animal Physiology (8 papers), Receptor Mechanisms and Signaling (6 papers) and Biochemical Analysis and Sensing Techniques (4 papers). Michael F. Johnson is often cited by papers focused on Neuropeptides and Animal Physiology (8 papers), Receptor Mechanisms and Signaling (6 papers) and Biochemical Analysis and Sensing Techniques (4 papers). Michael F. Johnson collaborates with scholars based in United States. Michael F. Johnson's co-authors include Jack D. Caldwell, Cort A. Pedersen, Arthur J. Prange, Gregory N. Ervin, Larry S. Birkemo, Jack T. Mosher, Mary K. Grizzle, Elizabeth E. Sugg, Dallas K. Croom and Michael K. James and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

Michael F. Johnson

14 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael F. Johnson United States	12	184	175	173	131	88	14	511
Nga Ching Wo United States	16	224 1.2×	148 0.8×	522 3.0×	229 1.7×	85 1.0×	28	616
Lex Van der Ploeg United States	11	103 0.6×	67 0.4×	265 1.5×	352 2.7×	36 0.4×	13	655
Maurice Manning United States	12	280 1.5×	152 0.9×	475 2.7×	186 1.4×	71 0.8×	25	650
Jana Škopková Czechia	10	81 0.4×	57 0.3×	201 1.2×	81 0.6×	63 0.7×	31	310
Krzysztof Bańkowski Poland	12	216 1.2×	137 0.8×	525 3.0×	234 1.8×	109 1.2×	18	718
Lena Löfberg Sweden	10	198 1.1×	219 1.3×	398 2.3×	120 0.9×	155 1.8×	10	860
Sarah Piper Australia	16	329 1.8×	189 1.1×	54 0.3×	236 1.8×	47 0.5×	22	734
Laura Cervini United States	12	191 1.0×	122 0.7×	45 0.3×	201 1.5×	134 1.5×	19	620
Aude Saulière France	11	431 2.3×	234 1.3×	107 0.6×	129 1.0×	20 0.2×	11	644
John Lowbridge United States	10	121 0.7×	80 0.5×	236 1.4×	78 0.6×	27 0.3×	16	331

Countries citing papers authored by Michael F. Johnson

Since Specialization

Citations

This map shows the geographic impact of Michael F. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael F. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael F. Johnson more than expected).

Fields of papers citing papers by Michael F. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael F. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael F. Johnson. The network helps show where Michael F. Johnson may publish in the future.

Co-authorship network of co-authors of Michael F. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael F. Johnson. A scholar is included among the top collaborators of Michael F. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael F. Johnson. Michael F. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Sherrill, Ronald G., Judd Berman, Dallas K. Croom, et al.. (2001). 1,4-Benzodiazepine Peripheral Cholecystokinin (CCK-A) Receptor Agonists. Bioorganic & Medicinal Chemistry Letters. 11(9). 1145–1148. 22 indexed citations

Mosher, Jack T., Larry S. Birkemo, Michael F. Johnson, & Gregory N. Ervin. (1998). Sulfated Cholecystokinin Induces Mild Taste Aversion Conditioning in Rats when Administered by Three Different Routes. Peptides. 19(5). 849–857. 16 indexed citations

Henke, Brad R., Christopher Aquino, Larry S. Birkemo, et al.. (1997). Optimization of 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists. Journal of Medicinal Chemistry. 40(17). 2706–2725. 63 indexed citations

Mosher, Jack T., et al.. (1996). Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning. Peptides. 17(3). 483–488. 9 indexed citations

Henke, Brad R., Timothy M. Willson, Elizabeth E. Sugg, et al.. (1996). 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A Agonists That Demonstrate Oral Activity as Satiety Agents. Journal of Medicinal Chemistry. 39(14). 2655–2658. 20 indexed citations

Willson, Timothy M., Brad R. Henke, Peter L. Myers, et al.. (1996). 3-[2-(N-Phenylacetamide)]-1,5-benzodiazepines: Orally Active, Binding Selective CCK-A Agonists. Journal of Medicinal Chemistry. 39(15). 3030–3034. 18 indexed citations

Hirst, Gavin C., Christopher Aquino, Dallas K. Croom, et al.. (1996). Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity (II): Optimization of the C3 Amino Substituent. Journal of Medicinal Chemistry. 39(26). 5236–5245. 31 indexed citations

Aquino, Christopher, Duncan Armour, Judd Berman, et al.. (1996). Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”. Journal of Medicinal Chemistry. 39(2). 562–569. 79 indexed citations

Dezube, Milana, Elizabeth E. Sugg, Larry S. Birkemo, et al.. (1995). Modification of Receptor Selectivity and Functional Activity in Cholecystokinin Peptoid Ligands. Journal of Medicinal Chemistry. 38(17). 3384–3390. 16 indexed citations

10.

Ervin, Gregory N., et al.. (1995). The effects of anorectic and aversive agents on deprivation-induced feeding and taste aversion conditioning in rats.. Journal of Pharmacology and Experimental Therapeutics. 273(3). 1203–1210. 39 indexed citations

11.

Ervin, Gregory N., Jack T. Mosher, Larry S. Birkemo, & Michael F. Johnson. (1995). Multiple, small doses of cholecystokinin octapeptide are more efficacious at inducing taste aversion conditioning than single, large doses. Peptides. 16(3). 539–545. 22 indexed citations

12.

Ervin, Gregory N., et al.. (1992). Aversion does not mediate sulfated cholecystokinin-8 (CCK-8)- or bombesin (BOM)-induced anorexia. Appetite. 19(2). 177–177. 1 indexed citations

13.

Caldwell, Jack D., et al.. (1986). Variations in concentration of oxytocin and vasopressin in the paraventricular nucleus of the hypothalamus during the estrous cycle in rats. Life Sciences. 38(25). 2311–2318. 68 indexed citations

14.

Pedersen, Cort A., et al.. (1985). Oxytocin antiserum delays onset of ovarian steroid-induced maternal behavior. Neuropeptides. 6(2). 175–182. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact